This potential therapeutic effect in hearing is in line with previous findings of elevated levels of vestibular schwannoma-secreted FGF2 being associated with better hearing (Dilwali et al., 2013, 2015). The gene discussed is FGF2; the disease is Vestibular schwannoma.